ASSESSMENT OF ADDITION DOCETAXEL TO ANDROGEN DEPRIVATION THERAPY FOR PATIENTS WITH HORMONESENSITIVE METASTATIC PROSTATE CANCER : EXPERIENCE OF THE ONCOLOGY/HEMATOLOGY CENTER OF MED VI UNIVERSITY HOSPITAL CENTER, MARRAKECH

Journal Title: International Journal Of Advances In Surgery - Year 2019, Vol 3, Issue 3

Abstract

Background: Prostate cancer (PCa) is a major health problem with more than three hundred thousand deaths worldwide. Androgen deprivation treatment (ADT) was the standard for first-line metastatic disease with survival ranging from 31 to 49 months. However, most patients developed ADT resistance with a median sensitivity duration estimated at 36 months. At an early stage, in patients with hormone-sensitive metastatic prostate cancer 3 randomized trials were performed, comparing 2 arms (ADT alone as standard to an experimental arm combining ADT with docetaxel), and have revealed survival outcomes that are not all statistically significant. The aim of this work is to assess the efficiency and the tolerance of the association ADT + docetaxel in the metastatic prostate cancer hormono-sensitive in 1st line. Methods : This is a retrospective study conducted from March 2015 until December 2017 in the Oncology/Hematology Center of the Med VI University Hospital Center in Marrakech. All patients under supervision and treatment for metastatic prostate cancer evaluated after 3, 6,9 and 12 months with a high volume disease are part of our study. Patients were assigned to docetaxel at a dose of 75 mg per square meter of body-surface area given every 3 weeks for six cycles cycles without prednisolone combined to medical castration by goserelin 10.8 mg and zoledronic acid. The parameters studied were epidemiological data, response rate, psa rate, and tolerance. Results : A total of 12 patients under supervision for metastatic prostate cancer were gathered in the Oncology / Hematology Center of the VI Med University Hospital Center in Marrakech. At the end of the 12-month evaluation period , 9 patients (75%) had a clinical benefit (partial response and clinical stability), , 2 patients had radiological progression. The proportion of patients who decreased their PSA level to less than 6 ng per milliliter at 12 months was 42%. A complete clinical response with motor recovery was observed in a patient with spinal metastases and spinal cord compression D5-D7. No death has been recorded. The toxicities mostly encountered were neutropenia with 42% grade 3-4 neutropenia and 17% febrile neutropenia, 17% grade 3 allergy reactions , 25% grade 3 diarrhea and 8% grade3 peripheral neuropathy. Conclusion : The results obtained in this small series are encouraging and have demonstrated the efficacy and tolerance of the ADT plus docetaxel combination. Our study suggests the importance of conducting further national studies for this type of patients given the prevalence of metastatic prostate cancer in Morocco.

Authors and Affiliations

Habib Diallo, Nora Naqos, Salma Elouarzazi, Hasnae Alaoui Mhamdi, Rhizlane Belbaraka

Keywords

Related Articles

OUR INITIAL EXPERIENCE WITH VAC SUCTION IN THE MANAGEMENT OF INFECTED WOUNDS: A PROSPECTIVE STUDY

Background: Management of infected wounds is not always simple and easy. Vacuum-assisted closure (VAC) is a wound healing therapy that utilizes a dressing system that continuously or intermittently applies a negative pre...

PARTIAL STERNAL RESECTIONS IN PRIMARY AND METASTATIC TUMORS WITH NON RIGID RECONSTRUCTION OF CHEST WALL

Various approaches have been described for thyroidectomy in the literature. Of late, minimal access approach has been explored through different routes like axillary, breast or anterior chest ,intraoral approaches. Advan...

INTRACRANIAL CHRONIC EPIDURAL HEMATOMAS: TECHNICAL NOTE

Intracranial chronic epidural hematomas can be rarely found in patients victims of head trauma. The diagnosis is usually delayed because of the absence of neurologic focus signs. Re-bleeding is possibly the underlying me...

IS THE RISK OF DELIRIUM REDUCED IN MINIMAL INVASIVE CARDIAC SURGERY

Background: The number of cardiac operations is steadily increasing in industrialized countries, being Delirium one of the most frequent postoperative complications. Aortic Valve Replacement by mini-invasive surgery has...

ARTIFICIAL INTELLIGENCE IN BREAST DISEASE MANAGEMENT:NO INNOVATION WITHOUT EVALUATION

Artificial intelligence (AI) in medicine and healthcare has been a particularly hot topic in recent years,such a rapidly progressing, highly innovative subject including not only diagnostic modalities but also interventi...

Download PDF file
  • EP ID EP638694
  • DOI -
  • Views 56
  • Downloads 0

How To Cite

Habib Diallo, Nora Naqos, Salma Elouarzazi, Hasnae Alaoui Mhamdi, Rhizlane Belbaraka (2019). ASSESSMENT OF ADDITION DOCETAXEL TO ANDROGEN DEPRIVATION THERAPY FOR PATIENTS WITH HORMONESENSITIVE METASTATIC PROSTATE CANCER : EXPERIENCE OF THE ONCOLOGY/HEMATOLOGY CENTER OF MED VI UNIVERSITY HOSPITAL CENTER, MARRAKECH. International Journal Of Advances In Surgery, 3(3), 10-12. https://europub.co.uk/articles/-A-638694